July 2026 3C GROUPS acquired 100% of Blue Ocean Robotics, the company behind UVD Robots. The transaction supports a sharpened strategic focus on autonomous UV-C disinfection solutions for healthcare, life sciences, and pharmaceutical environments.
March 2026 Blue Ocean Robotics appointed PSC Biotech as a pharmaceutical-sector partner for the U.S., Australia, and Singapore, expanding distribution and implementation of the UVD Robot Pharma platform for GMP-controlled and cleanroom environments.
March 2026 UVD Robots partnered with AB Scientific to expand UVD Robot Pharma deployment across the UK pharmaceutical industry. The collaboration targets automated UV-C disinfection, contamination control, and Annex 1 compliance in cleanrooms.
August 2025 Blue Ocean Robotics made a strategic decision to concentrate its operations on the UVD Robot platform, prioritizing autonomous UV-C disinfection technologies for healthcare and pharmaceutical applications.